Pancreatic cancer in Australia: Persistent Challenges and Priorities
The battle against pancreatic cancer in Australia demands urgent attention and a comprehensive strategy. This disease poses a significant health challenge, with alarming statistics that demand immediate action. According to recent data, pancreatic cancer-related deaths have nearly doubled in the past two decades, outpacing prostate cancer and only second to lung cancer in terms of cancer-related fatalities. This alarming trend underscores the need for a national health priority and sustained investment in research, clinical innovation, workforce development, and equitable access to care.
The lack of a formal population-wide screening program contributes to late diagnoses and poor survival rates. The five-year relative survival rate for pancreatic cancer is alarmingly low at 14% for the 2017-2021 period. This grim reality highlights the importance of early detection and timely interventions.
The quality of life for those living with pancreatic cancer is significantly impacted by the disease, with arduous treatments and high morbidity rates. This underscores the need for comprehensive supportive and palliative care, focusing on symptom management and patient-centered care.
Cancer Australia's National Pancreatic Cancer Roadmap provides a framework for collective action across 33 priority domains. This initiative aims to improve outcomes and survival for Australians diagnosed with pancreatic cancer. Practical, evidence-based resources have been developed in partnership with leading universities and the Pancare Foundation to support health professionals and patients. These resources address critical challenges such as early detection, timely diagnosis, pain management, and early integration of palliative care.
The University of Queensland has led the development of clinical guidance and educational tools focused on early detection and diagnosis. These resources assist primary care practitioners in recognizing symptoms, selecting appropriate investigations, and facilitating timely referrals to specialists. The University of Melbourne, in collaboration with HammondCare, the University of Queensland, and the University of Adelaide, has developed resources to improve access to pain management and early palliative care. These resources include standardized referral pathways, pain assessment tools, and culturally appropriate guidance for Aboriginal and Torres Strait Islander peoples.
Addressing the persistent challenges of pancreatic cancer requires a sustained, coordinated, and well-funded national response. Early detection technologies, surveillance of high-risk populations, personalized treatment approaches, supportive and palliative care, public awareness, and education are critical priority areas. Investment in research is essential to accelerate progress in these areas.
The bleak survival statistics and profound impact on quality of life demand urgent and sustained action. Pancreatic cancer must be recognized as a national health priority, supported by long-term investment in research, clinical innovation, workforce capability, and equitable access to care. By committing to earlier detection, personalized treatment approaches, and comprehensive supportive and palliative care, Australia can change the trajectory of this disease and offer hope to the thousands of families affected each year.
Dr. Mark Buzza (PhD, MBA) is Head of Research, Innovation, and Advocacy at the Pancare Foundation. Melanie Regan (RN, BHScNsg, GradDip Cancer Care, MN) is Special Projects Manager at the Pancare Foundation. The views expressed in this article reflect the authors' opinions and do not necessarily represent the official policy of the AMA, the MJA, or InSight+ unless stated.
To stay informed, subscribe to the free InSight+ weekly newsletter. It's available to all readers, not just registered medical practitioners. For article submissions, send a Word version to mjainsight-editor@ampco.com.au.
